Addex Therapeutics Ltd American Depositary Shares ADXN

$5.95 +2.59% at last close

Recent SEC Filings

FormDescriptionFiledDocument
6-K FORM 6-K 2026-07-08 View →
6-K FORM 6-K 2026-06-30 View →
6-K FORM 6-K 2026-06-25 View →
6-K FORM 6-K 2026-06-05 View →
20-F FORM 20-F 2026-05-15 View →
6-K FORM 6-K 2026-04-30 View →
6-K FORM 6-K 2026-04-29 View →
6-K FORM 6-K 2026-04-23 View →
6-K FORM 6-K 2026-04-21 View →
6-K FORM 6-K 2026-02-03 View →
6-K FORM 6-K 2026-01-07 View →
6-K FORM 6-K 2025-12-10 View →
424B5 424B5 2025-12-10 View →
6-K FORM 6-K 2025-12-04 View →
6-K FORM 6-K 2025-10-29 View →
6-K FORM 6-K 2025-09-30 View →
6-K FORM 6-K 2025-09-23 View →
6-K FORM 6-K 2025-06-30 View →
6-K FORM 6-K 2025-06-25 View →
6-K FORM 6-K 2025-06-20 View →
6-K FORM 6-K 2025-06-06 View →
20-F FORM 20-F 2025-05-15 View →
6-K FORM 6-K 2025-05-12 View →
6-K FORM 6-K 2025-04-30 View →
6-K FORM 6-K 2025-04-25 View →
6-K FORM 6-K 2025-04-17 View →
6-K FORM 6-K 2024-11-22 View →
6-K FORM 6-K 2024-11-12 View →
6-K FORM 6-K 2024-09-30 View →
6-K FORM 6-K 2024-09-19 View →
6-K FORM 6-K 2024-08-27 View →
6-K FORM 6-K 2024-07-22 View →
6-K FORM 6-K 2024-07-15 View →
6-K FORM 6-K 2024-07-01 View →
6-K FORM 6-K 2024-06-06 View →
6-K FORM 6-K 2024-06-05 View →
6-K FORM 6-K 2024-04-29 View →
20-F FORM 20-F 2024-04-18 View →
6-K FORM 6-K 2024-04-18 View →
6-K FORM 6-K 2024-04-03 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$5.95
Market Cap
$7.53 million
52-Week Range
$5.04 – $12.05
Average Volume
4K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.